SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-12.1%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$371M
AUM Growth
+$371M
(-33%)
Cap. Flow
-$76.3M
Cap. Flow
% of AUM
-20.55%
Top 10 Holdings %
Top 10 Hldgs %
58.47%
Holding
138
New
19
Increased
20
Reduced
26
Closed
49
Top Buys
| 1 |
Viatris
VTRS
|
$13.3M |
| 2 |
SHPG
Shire pic
SHPG
|
$13M |
| 3 |
Ituran Location and Control
ITRN
|
$9.28M |
| 4 |
Pfizer
PFE
|
$7.41M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$4.33M |
Top Sells
| 1 |
AbbVie
ABBV
|
$21.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
$8.36M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.09M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$5.76M |
| 5 |
Incyte
INCY
|
$5.6M |
Sector Composition
| 1 | Healthcare | 77.34% |
| 2 | Technology | 4.69% |
| 3 | Utilities | 3.59% |
| 4 | Communication Services | 2.82% |
| 5 | Financials | 1.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$141B
| $42.3M | 9.17% | 1,426,612 +250,000 | +21% | +$7.41M |
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $38.8M | 8.41% | 725,200 -59,650 | -8% | -$3.19M |
|
3
Biogen
BIIB
$19.4B
| $30.9M | 6.71% | 118,850 -5,000 | -4% | -$1.3M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $26.8M | 5.81% | 100,000 | – | – |
|
|
SHPG
5
DELISTED
Shire pic
SHPG
| $16.5M | 3.57% | 188,676 +148,676 | +372% | +$13M |
|
6
Gilead Sciences
GILD
$140B
| $15.9M | 3.44% | 172,700 +30,000 | +21% | +$2.76M |
|
|
7
Viatris
VTRS
$12.3B
| $13.3M | 2.89% | +287,827 | New | +$13.3M |
|
8
Ormat Technologies
ORA
$5.56B
| $13.3M | 2.88% | 322,193 +49,731 | +18% | +$2.05M |
|
|
CELG
9
DELISTED
Celgene Corp
CELG
| $10M | 2.17% | 100,000 -47,200 | -32% | -$4.72M |
|
|
10
Ituran Location and Control
ITRN
$671M
| $9.28M | 2.01% | +471,584 | New | +$9.28M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.57M | 1.21% | 40,000 -19,164 | -32% | -$2.67M |
|
12
Visa
V
$683B
| $5.15M | 1.12% | 67,369 +30,769 | +84% | +$2.35M |
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.39M | 0.95% | 70,000 +30,000 | +75% | +$1.88M |
|
|
14
Alphabet (Google) Class A
GOOGL
$2.57T
| $4.33M | 0.94% | +5,680 | New | +$4.33M |
|
15
Vanda Pharmaceuticals
VNDA
$279M
| $4.28M | 0.93% | 512,051 +50,000 | +11% | +$418K |
|
16
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.19M | 0.91% | 150,000 +50,000 | +50% | +$1.4M |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| $3.94M | 0.85% | 123,000 +30,000 | +32% | +$962K |
|
|
ADMS
18
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $3.9M | 0.85% | 270,000 +120,000 | +80% | +$1.74M |
|
|
FPRX
19
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.25M | 0.7% | 80,000 -65,000 | -45% | -$2.64M |
|
20
Elbit Systems
ESLT
$22.3B
| $3.24M | 0.7% | +34,456 | New | +$3.24M |
|
21
Advance Auto Parts
AAP
$3.66B
| $3.23M | 0.7% | 20,136 +4,581 | +29% | +$735K |
|
22
Charter Communications
CHTR
$36.3B
| $3.23M | 0.7% | 15,930 +11,904 | +296% | +$2.41M |
|
|
MRNS
23
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.07M | 0.67% | 570,908 | – | – |
|
|
PTNR
24
DELISTED
Partner Communications
PTNR
| $2.91M | 0.63% | 624,230 +6,279 | +1% | +$29.3K |
|
25
MacroGenics
MGNX
$112M
| $2.87M | 0.62% | 153,000 | – | – |
|